Berkshire Asset Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$253K Buy
1,144
+36
+3% +$9.96K 0.01% 242
2026
Q1
$327K Buy
1,108
+26
+2% +$7.72K 0.01% 208
2025
Q4
$295K Sell
1,082
-91
-8% -$24.7K 0.01% 219
2025
Q3
$317K Buy
1,173
+4
+0.3% +$1.09K 0.01% 237
2025
Q2
$322K Buy
1,169
+4
+0.3% +$1.09K 0.01% 223
2025
Q1
$329K Buy
+1,165
New +$287K 0.02% 224
2020
Q3
Sell
-1,255
Closed -$204K 167
2020
Q2
$204K Hold
1,255
0.02% 162
2020
Q1
$217K Sell
1,255
-939
-43% -$187K 0.02% 185
2019
Q4
$440K Sell
2,194
-138
-6% -$28.3K 0.04% 131
2019
Q3
$493K Buy
2,332
+138
+6% +$28.8K 0.04% 140
2019
Q2
$426K Hold
2,194
0.04% 147
2019
Q1
$361K Sell
2,194
-13
-0.6% -$2.3K 0.03% 169
2018
Q4
$415K Buy
2,207
+13
+0.6% +$2.4K 0.04% 147
2018
Q3
$373K Buy
2,194
+10
+0.5% +$1.68K 0.03% 170
2018
Q2
$358K Hold
2,184
0.03% 160
2018
Q1
$353K Buy
+2,184
New +$348K 0.03% 159

Other funds holding CME

Berkshire Asset Management's CME Position: Q2 2026 in Review

Berkshire Asset Management increased its CME Group (CME) stake by 3.2% in Q2 2026, buying an estimated $9.96K and bringing the position to 1,144 shares worth $253K. The position accounts for 0.01% of the portfolio, ranked #242.

Berkshire Asset Management first reported a position in CME in Q1 2018 and has held it in 16 quarters since. The position peaked at $493K in Q3 2019. 956 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Berkshire Asset Management held 1,144 shares of CME Group worth $253K as of Q2 2026.
  • Berkshire Asset Management bought 36 CME Group shares in Q2 2026, an estimated $9.96K.
  • CME Group made up 0.01% of Berkshire Asset Management's portfolio in Q2 2026, its #242 holding.
  • Berkshire Asset Management first reported a position in CME Group in Q1 2018 and has held it in 16 quarters since.
  • Berkshire Asset Management's CME Group position peaked at $493K in Q3 2019.
  • 956 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Berkshire Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.